4//SEC Filing
Clyburn Frank 4
Accession 0001610717-24-000416
CIK 0001628171other
Filed
Aug 6, 8:00 PM ET
Accepted
Aug 7, 5:34 PM ET
Size
6.7 KB
Accession
0001610717-24-000416
Insider Transaction Report
Form 4
Clyburn Frank
Director
Transactions
- Award
Common Stock
2024-08-05+6,932→ 6,932 total - Award
Stock Option (Right to Buy)
2024-08-05+27,744→ 27,744 totalExercise: $42.48Exp: 2034-08-05→ Common Stock (27,744 underlying)
Footnotes (2)
- [F1]Includes 6,932 restricted stock units.
- [F2]The option becomes exercisable as it vests and the shares subject to the option vest with respect to 1/36 of the shares subject thereto on each monthly anniversary of August 5, 2024, subject to the reporting person's continued employment or service relationship with the Company on each such vesting date.
Documents
Issuer
Revolution Medicines, Inc.
CIK 0001628171
Entity typeother
Related Parties
1- filerCIK 0001763963
Filing Metadata
- Form type
- 4
- Filed
- Aug 6, 8:00 PM ET
- Accepted
- Aug 7, 5:34 PM ET
- Size
- 6.7 KB